Sandbox/kiran: Difference between revisions
< Sandbox
Kiran Singh (talk | contribs) No edit summary |
Kiran Singh (talk | contribs) No edit summary |
||
| (17 intermediate revisions by the same user not shown) | |||
| Line 42: | Line 42: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
The prevalence of substance/medication-induced depressive disorder is 260 per 100,000 (0.26%) of the overall population.<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | The prevalence of substance/medication-induced [[Clinical depression|depressive disorder]] is 260 per 100,000 (0.26%) of the overall population.<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | ||
==Risk Factors== | ==Risk Factors== | ||
*[[Antisocial behavior]] | *[[Antisocial behavior]] | ||
*Alcohol or drug use disorders | *[[Alcohol]] or drug use disorders | ||
*History of drug induced [[depression]] | *History of drug induced [[depression]] | ||
*Higher family history of substance use disorders | *Higher family history of substance use disorders | ||
| Line 100: | Line 100: | ||
==Risk Factors== | ==Risk Factors== | ||
*CVA | *[[CVA]] | ||
:*Left frontal strokes | :*Left frontal strokes | ||
| Line 148: | Line 148: | ||
*G.The disturbance is not better explained by the symptoms of another mental disorder,including fear, anxiety, and avoidance of situations associated with panic-like symptoms | *G.The disturbance is not better explained by the symptoms of another mental disorder,including fear, anxiety, and avoidance of situations associated with panic-like symptoms | ||
or other incapacitating symptoms (as in [[agoraphobia]]): objects or situations related to obsessions (as in [[obsessive-compulsive disorder]]); reminders of traumatic events (as in posttraumatic stress disorder); separation from home or attachment figures (as in separation anxiety disorder); or social situations (as in social anxiety disorder). | or other incapacitating symptoms (as in [[agoraphobia]]): objects or situations related to [[OCD|obsessions]] (as in [[obsessive-compulsive disorder]]); reminders of traumatic events (as in [[posttraumatic stress disorder]]); separation from home or attachment figures (as in [[separation anxiety disorder]]); or social situations (as in [[social anxiety disorder]]). | ||
}} | }} | ||
| Line 189: | Line 189: | ||
===DSM-V Diagnostic Criteria for Substance/Medication-Induced Anxiety Disorder <ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>=== | ===DSM-V Diagnostic Criteria for Substance/Medication-Induced Anxiety Disorder <ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>=== | ||
{{cquote| | {{cquote| | ||
*A.Panic attacks or anxiety is predominant in the clinical picture. | *A.[[Panic attacks]] or anxiety is predominant in the clinical picture. | ||
'''''AND''''' | '''''AND''''' | ||
| Line 201: | Line 201: | ||
'''''AND''''' | '''''AND''''' | ||
*C.The disturbance is not better explained by an anxiety disorder that is not substance/medication-induced. Such evidence of an independent anxiety disorder could include | *C.The disturbance is not better explained by an anxiety disorder that is not substance/medication-induced. Such evidence of an independent [[anxiety disorder]] could include | ||
the following: | the following: | ||
| Line 274: | Line 274: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
The prevalence of anxiety disorder due to another medical condition is unclear in the overall population.<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | The prevalence of [[anxiety disorder]] due to another medical condition is unclear in the overall population.<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | ||
| Line 288: | Line 288: | ||
*[[Delirium]] | *[[Delirium]] | ||
*Illness anxiety disorder | *Illness [[anxiety disorder]] | ||
*Mixed presentation of symptoms (e.g., mood and anxiety) | *Mixed presentation of symptoms (e.g., mood and anxiety) | ||
*Other specified or unspecified anxiety disorder | *Other specified or unspecified anxiety disorder | ||
*Substance/medication-induced anxiety disorder | *Substance/medication-induced [[anxiety disorder]] | ||
:*Corticosteroids | :*Corticosteroids | ||
:*[[Estrogens]] | :*[[Estrogens]] | ||
| Line 321: | Line 321: | ||
'''''AND''''' | '''''AND''''' | ||
*E.The skin picking is not better explained by symptoms of another mental disorder (e.g., [[delusions]] or tactile hallucinations in a psychotic disorder, attempts to improve a perceived defect or flaw in appearance in [[body dysmorphic disorder]], stereotypies in [[stereotypic movement disorder]], or intention to harm oneself in non suicidal self-injury). | *E.The skin picking is not better explained by symptoms of another mental disorder (e.g., [[delusions]] or tactile [[hallucinations]] in a psychotic disorder, attempts to improve a perceived defect or flaw in appearance in [[body dysmorphic disorder]], stereotypies in [[stereotypic movement disorder]], or intention to harm oneself in non suicidal self-injury). | ||
}} | }} | ||
| Line 351: | Line 351: | ||
*Other obsessive-compulsive and related disorders | *Other obsessive-compulsive and related disorders | ||
:*[[Body dysmorphic disorder]] | :*[[Body dysmorphic disorder]] | ||
*Other disorders | *Other disorders | ||
*Other medical conditions | *Other medical conditions | ||
:*[[Acne]] | :*[[Acne]] | ||
:*[[Scabies]] | :*[[Scabies]] | ||
*Psychotic disorder | *Psychotic disorder | ||
:*[[Delusion]] | :*[[Delusion]] | ||
| Line 386: | Line 383: | ||
:*The symptoms precede the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute | :*The symptoms precede the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute | ||
withdrawal or severe intoxication; or there is other evidence suggesting the existence of an independent non-substance/medication-induced obsessive-compulsive and related disorder (e.g., a history of recurrent non-substance/medication related episodes). | withdrawal or severe intoxication; or there is other evidence suggesting the existence of an independent non-substance/medication-induced [[OCD|obsessive-compulsive]] and related disorder (e.g., a history of recurrent non-substance/medication related episodes). | ||
'''''AND''''' | '''''AND''''' | ||
| Line 418: | Line 415: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
*[[Delirium]] | *[[Delirium]] | ||
*[[OCD|Obsessive-compulsive]] and related disorder (i.e., not induced by a substance) | |||
*Obsessive-compulsive and related disorder (i.e., not induced by a substance) | *[[OCD|Obsessive-compulsive]] and related disorder due to another medical condition | ||
*Obsessive-compulsive and related disorder due to another medical condition | |||
*Substance intoxication<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | *Substance intoxication<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | ||
''' | ''' Obsessive-Compulsive and Related Disorder Due to Another Medical Condition''' | ||
==Diagnostic Criteria== | ==Diagnostic Criteria== | ||
| Line 473: | Line 469: | ||
'''Major or Mild Neurocognitive Disorder Due to Another Medical Condition''' | '''Major or Mild Neurocognitive Disorder Due to Another Medical Condition''' | ||
==Diagnostic Criteria=====DSM-V Diagnostic Criteria for Major or Mild Neurocognitive Disorder Due to Another Medical Condition <ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>=== | ==Diagnostic Criteria== | ||
===DSM-V Diagnostic Criteria for Major or Mild Neurocognitive Disorder Due to Another Medical Condition <ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>=== | |||
{{cquote| | {{cquote| | ||
| Line 500: | Line 498: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
*Other major or mild neurocognitive disorder<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | *Other major or mild neurocognitive disorder<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | ||
'''Major or Mild Neurocognitive Disorder Due to Multiple Etiologies''' | |||
==Diagnostic Criteria== | |||
===DSM-V Diagnostic Criteria for Major or Mild Neurocognitive Disorder Due to Multiple Etiologies <ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>=== | |||
{{cquote| | |||
*A.The criteria are met for major or mild neurocognitive disorder. | |||
'''''AND''''' | |||
*B.There is evidence from the history, physical examination, or laboratory findings that the neurocognitive disorder is the pathophysiological consequence of more than one etiological process, excluding substances (e.g., neurocognitive disorder due to [[Alzheimer’s disease]] with subsequent development of vascular neurocognitive disorder). | |||
<SMALL>''Note:Please refer to the diagnostic criteria for the various neurocognitive disorders due to specific medical conditions for guidance on establishing the particular etiologies .''</SMALL> | |||
'''''AND''''' | |||
*C.The cognitive deficits are not better explained by another mental disorder and do not occur exclusively during the course of a [[delirium]]. | |||
}} | |||
==References== | |||
{{reflist|2}} | |||
[[Category:DSM-V Diagnostic Criteria]] | |||
[[Category:Psychiatric Disease]] | |||
[[Category:Psychiatry]] | |||
'''Other (or Unknown) Substance Intoxication''' | |||
==Diagnostic Criteria== | |||
===DSM-V Diagnostic Criteria for Other (or Unknown) Substance Intoxication<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>=== | |||
{{cquote| | |||
*A.The development of a reversible substance-specific syndrome attributable to recent ingestion of (or exposure to) a substance that is not listed elsewhere or is unknown. | |||
'''''AND''''' | |||
*B.Clinically significant problematic behavioral or psychological changes that are attributable to the effect of the substance on the central nervous system (e.g., impaired motor | |||
coordination, psychomotor agitation or retardation, euphoria, anxiety, belligerence, mood lability, cognitive impairment, impaired judgment, social withdrawal) and develop | |||
during, or shortly after, use of the substance. | |||
'''''AND''''' | |||
*C.The signs or symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including intoxication with another substance. | |||
}} | |||
==References== | |||
{{reflist|2}} | |||
[[Category:DSM-V Diagnostic Criteria]] | |||
[[Category:Psychiatric Disease]] | |||
[[Category:Psychiatry]] | |||
==Epidemiology and Demographics== | |||
===Prevalence=== | |||
The prevalence of Other (or Unknown) Substance Intoxication is unknown.<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | |||
==Differential Diagnosis== | |||
*Different types of other (or unknown) substance-related disorders | |||
*Other toxic, metabolic, traumatic, neoplastic, vascular, or infectious disorders that impair brain function and cognition | |||
*Substance intoxication or other substance/medication-induced disorders | |||
*Use of Other or unknown substance, without meeting criteria for other (or unknown)substance intoxication<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | |||
'''''Other (or Unknown) Substance Use Disorder''''' | |||
==Diagnostic Criteria== | |||
===DSM-V Diagnostic Criteria for Other (or Unknown) Substance Use Disorder <ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>=== | |||
{{cquote| | |||
*A.A problematic pattern of use of an intoxicating substance not able to be classified within the [[alcohol]]; [[caffeine]]; [[cannabis]]; [[hallucinogen]] ([[phencyclidine]] and others); inhalant;[[opioid]]; [[sedative, hypnotic, or anxiolytic]]; stimulant; or tobacco categories and leading to clinically significant impairment or distress, as manifested by at least two of the following, occurring within a 12-month period: | |||
*1.The substance is often taken in larger amounts or over a longer period than was intended. | |||
*2.There is a persistent desire or unsuccessful efforts to cut down or control use of the substance. | |||
*3.A great deal of time is spent in activities necessary to obtain the substance, use the substance, or recover from its effects. | |||
*4.Craving, or a strong desire or urge to use the substance. | |||
*5.Recurrent use of the substance resulting in a failure to fulfill major role obligations at work, school, or home. | |||
*6.Continued use of the substance despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of its use. | |||
*7.Important social, occupational, or recreational activities are given up or reduced because of use of the substance. | |||
*8.Recurrent use of the substance in situations in which it is physically hazardous. | |||
*9.Use of the substance is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated | |||
by the substance. | |||
*10.Tolerance, as defined by either of the following: | |||
::*a.A need for markedly increased amounts of the substance to achieve intoxication or desired effect. | |||
::*b.A markedly diminished effect with continued use of the same amount of the substance. | |||
*11.Withdrawal, as manifested by either of the following: | |||
::*a.The characteristic withdrawal syndrome for other (or unknown) substance (refer to Criteria A and B of the criteria sets for other [or unknown] substance withdrawal). | |||
::*b.The substance (or a closely related substance) is taken to relieve or avoid withdrawal symptoms. | |||
Specify if: | |||
*In early remission: After full criteria for other (or unknown) substance use disorder were previously met, none of the criteria for other (or unknown) substance use disorder have been met for at least 3 months but for less than 12 months (with the exception that Criterion A4, “Craving, or a strong desire or urge to use the substance,” may be met). | |||
*In sustained remission: After full criteria for other (or unknown) substance use disorder were previously met, none of the criteria for other (or unknown) substance use disorder | |||
have been met at any time during a period of 12 months or longer (with the exception that Criterion A4, “Craving, or a strong desire or urge to use the substance,”may be met). | |||
Specify if: | |||
*In a controlled environment: This additional specifier is used if the individual is in an environment where access to the substance is restricted. | |||
}} | |||
==References== | |||
{{reflist|2}} | |||
[[Category:DSM-V Diagnostic Criteria]] | |||
[[Category:Psychiatric Disease]] | |||
[[Category:Psychiatry]] | |||
==Risk Factors== | |||
*[[Antisocial personality disorder]] | |||
*Behavioral disinhibition | |||
*[[Conduct disorder]] | |||
*Childhood maltreatment or trauma | |||
*Early onset of substance problems | |||
*Easy availability of the substance | |||
*Limited early self-control<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | |||
==Differential Diagnosis== | |||
*Other (or unknown) substance/medication-induced disorder | |||
:*[[Anxiety disorder]] | |||
:*[[Delirium]] | |||
:*[[Depressive disorder]] | |||
:*Major or mild neurocognitive disorder | |||
:*Psychotic disorder | |||
:*[[Sexual dysfunction]] | |||
:*[[Sleep disorder]] | |||
*Other medical conditions | |||
*Substance use disorders | |||
*Use of Other or unknown substances without meeting criteria for other (or unknown) substance use disorder<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | |||
'''''Other (or Unknown) Substance Withdrawal''''' | |||
==Diagnostic Criteria== | |||
===DSM-V Diagnostic Criteria for Other (or Unknown) Substance Withdrawal <ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>=== | |||
{{cquote| | |||
*A.Cessation of (or reduction in) use of a substance that has been heavy and prolonged. | |||
'''''AND''''' | |||
*B.The development of a substance-specific syndrome shortly after the cessation of (or reduction in) substance use. | |||
'''''AND''''' | |||
*C.The substance-specific syndrome causes clinically significant distress or impairment in social, occupational, or other important areas of functioning. | |||
'''''AND''''' | |||
*D.The symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including withdrawal from another substance. | |||
'''''AND''''' | |||
*E.The substance involved cannot be classified under any of the other substance categories ([[alcohol]]; [[caffeine]]; [[cannabis]]; [[opioids]]; [[Benzodiazepines|sedatives, hypnotics, or anxiolytics]]; stimulants; or tobacco) or is unknown. | |||
}} | |||
==References== | |||
{{reflist|2}} | |||
[[Category:DSM-V Diagnostic Criteria]] | |||
[[Category:Psychiatric Disease]] | |||
[[Category:Psychiatry]] | |||
==Epidemiology and Demographics== | |||
===Prevalence=== | |||
The prevalence of Other (or Unknown) Substance Withdrawal is unknown.<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | |||
==Differential Diagnosis== | |||
*Dose reduction after extended dosing, but not meeting the criteria for other (or unknown)substance withdrawal | |||
*Different types of other (or unknown) substance-related disorders | |||
*Other toxic, metabolic, traumatic, neoplastic, vascular, or infectious disorders that impair brain function and cognition | |||
*Substance withdrawal or other substance/medication-induced disorders<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | |||
'''Personality Change Due to Another Medical Condition''' | |||
==Diagnostic Criteria== | |||
===DSM-V Diagnostic Criteria for Personality Change Due to Another Medical Condition<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>=== | |||
{{cquote| | |||
*A.A persistent personality disturbance that represents a change from the individual’s previous characteristic personality pattern. | |||
<SMALL>''Note:In children, the disturbance involves a marked deviation from normal development or a significant change in the child’s usual behavior patterns, lasting at least | |||
1 year.''</SMALL> | |||
'''''AND''''' | |||
*B.There is evidence from the history, physical examination, or laboratory findings that the disturbance is the direct pathophysiological consequence of another medical condition. | |||
'''''AND''''' | |||
*C.The disturbance is not better explained by another mental disorder (including another mental disorder due to another medical condition). | |||
'''''AND''''' | |||
*D.The disturbance does not occur exclusively during the course of a [[delirium]]. | |||
'''''AND''''' | |||
E.The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning. | |||
Specify whether: | |||
*Labile type: If the predominant feature is affective lability. | |||
*Disinhibited type: If the predominant feature is poor impulse control as evidenced by sexual indiscretions, etc. | |||
*Aggressive type: If the predominant feature is aggressive behavior. | |||
*Apathetic type: If the predominant feature is marked apathy and indifference. | |||
*Paranoid type: If the predominant feature is suspiciousness or paranoid ideation. | |||
*Other type: If the presentation is not characterized by any of the above subtypes. | |||
*Combined type: If more than one feature predominates in the clinical picture. | |||
Unspecified type | |||
}} | |||
==References== | |||
{{reflist|2}} | |||
[[Category:DSM-V Diagnostic Criteria]] | |||
[[Category:Psychiatric Disease]] | |||
[[Category:Psychiatry]] | |||
==Differential Diagnosis== | |||
*Another mental disorder due to another medical condition | |||
:*[[Depressive disorder]] due to brain tumor | |||
*Chronic medical conditions associated with pain and disability | |||
*[[Delirium]] or major neurocognitive disorder | |||
*Other mental disorders | |||
:*[[Bipolar disorder]] | |||
:*[[Conduct disorders]] | |||
:*[[Delusional disorder]] | |||
:*[[Depressive disorder]] | |||
:*[[Panic disorder]] | |||
:*[[Schizophrenia]] | |||
*Other personality disorders | |||
*Substance use disorders<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | |||
Latest revision as of 16:32, 10 November 2014
Substance/Medication-Induced Depressive Disorder
Diagnostic Criteria
DSM-V Diagnostic Criteria for Substance/Medication-Induced Depressive Disorder [1]
| “ |
AND
(1)and(2):
The symptoms preceded the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute withdrawal or severe intoxication; or there is other evidence suggesting the existence of an independent non-substance/medication-induced depressive disorder (e.g., a history of recurrent non-substance/medication-related episodes). AND
AND
Note:This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and when they are sufficiently severe to warrant clinical attention. . |
” |
References
- ↑ Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
Epidemiology and Demographics
Prevalence
The prevalence of substance/medication-induced depressive disorder is 260 per 100,000 (0.26%) of the overall population.[1]
Risk Factors
- Antisocial behavior
- Alcohol or drug use disorders
- History of drug induced depression
- Higher family history of substance use disorders
- History of stressful life events
- Major depressive disorder
- Psychosocial stressors
- Specific type of medication[1]
Differential Diagnosis
- Depressive disorder due to another medical condition
- Primary depressive disorder
- Substance intoxication and withdrawal[1]
Depressive Disorder Due to Another Medical Condition
Diagnostic Criteria
DSM-V Diagnostic Criteria for Depressive Disorder Due to Another Medical Condition [1]
| “ |
AND
AND
AND
AND
|
” |
References
Risk Factors
- Left frontal strokes
Differential Diagnosis
- Adjustment disorders
- Depressive disorders not due to another medical condition
- Medication-induced depressive disorder
- Alpha-interferon
- steroids
Specific Phobia
Diagnostic Criteria
DSM-V Diagnostic Criteria for Specific Phobia[1]
| “ |
Note:In children, the fear or anxiety may be expressed by crying, tantrums, freezing, or clinging . AND
AND
AND
AND
AND
AND
or other incapacitating symptoms (as in agoraphobia): objects or situations related to obsessions (as in obsessive-compulsive disorder); reminders of traumatic events (as in posttraumatic stress disorder); separation from home or attachment figures (as in separation anxiety disorder); or social situations (as in social anxiety disorder). |
” |
References
- ↑ Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
Epidemilogy and Demographics
Prevalence
The 12 month prevalence of specific phobia is 7,000-9,000 per 100,000 (7%-9%) of the overall population.[1]
Risk Factors
- Behavioral inhibition
- Genetic predisposition
- Negative affectivity (neuroticism)
- Parental over protectiveness
- Parental loss and separation
- Physical and sexual abuse[1]
Differential Diagnosis
- Agoraphobia
- Eating disorders
- Obsessive-compulsive disorder
- Panic disorder
- Schizophrenia spectrum and other psychotic disorders
- Separation anxiety disorder
- Social anxiety disorder
- Trauma- and stressor-related disorders[1]
Substance/Medication-Induced Anxiety Disorder
Diagnostic Criteria
DSM-V Diagnostic Criteria for Substance/Medication-Induced Anxiety Disorder [1]
| “ |
AND
AND
the following:
(e.g., a history of recurrent non-substance/medication-related episodes). AND
AND
Note:This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and they are sufficiently severe to warrant clinical attention .
|
” |
References
Epidemiology and Demographics
Prevalence
The prevalence of substance/medication-induced anxiety disorder is not clear in the overall population.[1]
Differential Diagnosis
- Anxiety disorder (i.e., not induced by a substance/medication)
- Anxiety disorder due to another medical condition
- Delirium
- Substance intoxication and substance withdrawal[1]
Anxiety Disorder Due to Another Medical Condition
Diagnostic Criteria
DSM-V Diagnostic Criteria for Anxiety Disorder Due to Another Medical Condition [1]
{{cquote|
- A.Panic attacks or anxiety is predominant in the clinical picture.
AND
- B.There is evidence from the history, physical examination, or laboratory findings that the disturbance is the direct pathophysiological consequence of another medical condition.
AND
- C.The disturbance is not better explained by another mental disorder.
AND
- D.The disturbance does not occur exclusively during the course of a delirium.
AND
- E.The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.
References
- ↑ 1.0 1.1 1.2 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
Epidemiology and Demographics
Prevalence
The prevalence of anxiety disorder due to another medical condition is unclear in the overall population.[1]
Differential Diagnosis
- Associated feature of another mental disorder
- Anxiety disorder (not due to a known medical condition).
- Delirium
- Illness anxiety disorder
- Mixed presentation of symptoms (e.g., mood and anxiety)
- Other specified or unspecified anxiety disorder
- Substance/medication-induced anxiety disorder
Excoriation (Skin-Picking) Disorder
Diagnostic Criteria
DSM-V Diagnostic Criteria for Excoriation (Skin-Picking) Disorder [1]
| “ |
AND
AND
AND
AND
|
” |
References
- ↑ 1.0 1.1 1.2 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
Epidemiology and Demographics
Prevalence
The prevalence of excoriation (Skin-Picking) disorder is 1,400 per 100,000 (1.4%) of the overall population.[1]
Risk Factors
- Genetic predisposition
- obsessive-compulsive disorder(OCD)[1]
Differential Diagnosis
- Neurodevelopmental disorders
- Other obsessive-compulsive and related disorders
- Other disorders
- Other medical conditions
- Psychotic disorder
- Delusion
- Tactile hallucination
- Somatic symptom and related disorders
- Substance/medication-induced disorders
Substance/Medication-Induced Obsessive-Compulsive and Related Disorder
Diagnostic Criteria
DSM-V Diagnostic Criteria for Substance/Medication-Induced Obsessive-Compulsive and Related Disorder [1]
| “ |
AND
AND
withdrawal or severe intoxication; or there is other evidence suggesting the existence of an independent non-substance/medication-induced obsessive-compulsive and related disorder (e.g., a history of recurrent non-substance/medication related episodes). AND
AND
|
” |
References
- ↑ 1.0 1.1 1.2 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
Epidemiology and Demographics
Prevalence
The prevalence of substance induced obsessive-compulsive and related disorder is very rare.[1]
Differential Diagnosis
- Delirium
- Obsessive-compulsive and related disorder (i.e., not induced by a substance)
- Obsessive-compulsive and related disorder due to another medical condition
- Substance intoxication[1]
Obsessive-Compulsive and Related Disorder Due to Another Medical Condition
Diagnostic Criteria
DSM-V Diagnostic Criteria for Obsessive-Compulsive and Related Disorder Due to Another Medical Condition [1]
| “ |
A.Obsessions, compulsions, preoccupations with appearance, hoarding, skin picking, hair pulling, other body-focused repetitive behaviors, or other symptoms characteristic 0f obsessive-compulsive and related disorder predominate in the clinical picture. B.There is evidence from the history, physical examination, or laboratory findings that the disturbance is the direct pathophysiological consequence of another medical condition. C.The disturbance is not better explained by another mental disorder. D.The disturbance does not occur exclusively during the course of a delirium. E.The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning
|
” |
References
- ↑ 1.0 1.1 1.2 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
Differential Diagnosis
- Associated feature of another mental disorder
- Illness anxiety disorder
- Mixed presentation of symptoms (e.g., mood and obsessive-compulsive and related disorder symptoms).
- Obsessive-compulsive and related disorders (primary)
- Other specified obsessive-compulsive and related disorder or unspecified obsessive compulsive and related disorder
- Substance/medication-induced obsessive-compulsive and related disorders
Major or Mild Neurocognitive Disorder Due to Another Medical Condition
Diagnostic Criteria
DSM-V Diagnostic Criteria for Major or Mild Neurocognitive Disorder Due to Another Medical Condition [1]
| “ |
AND
condition. AND
|
” |
References
- ↑ Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
Differential Diagnosis
- Other major or mild neurocognitive disorder[1]
Major or Mild Neurocognitive Disorder Due to Multiple Etiologies
Diagnostic Criteria
DSM-V Diagnostic Criteria for Major or Mild Neurocognitive Disorder Due to Multiple Etiologies [1]
| “ |
AND
Note:Please refer to the diagnostic criteria for the various neurocognitive disorders due to specific medical conditions for guidance on establishing the particular etiologies . AND
|
” |
References
- ↑ 1.0 1.1 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
Other (or Unknown) Substance Intoxication
Diagnostic Criteria
DSM-V Diagnostic Criteria for Other (or Unknown) Substance Intoxication[1]
| “ |
AND
coordination, psychomotor agitation or retardation, euphoria, anxiety, belligerence, mood lability, cognitive impairment, impaired judgment, social withdrawal) and develop during, or shortly after, use of the substance. AND
|
” |
References
- ↑ Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
Epidemiology and Demographics
Prevalence
The prevalence of Other (or Unknown) Substance Intoxication is unknown.[1]
Differential Diagnosis
- Different types of other (or unknown) substance-related disorders
- Other toxic, metabolic, traumatic, neoplastic, vascular, or infectious disorders that impair brain function and cognition
- Substance intoxication or other substance/medication-induced disorders
- Use of Other or unknown substance, without meeting criteria for other (or unknown)substance intoxication[1]
Other (or Unknown) Substance Use Disorder
Diagnostic Criteria
DSM-V Diagnostic Criteria for Other (or Unknown) Substance Use Disorder [1]
| “ |
by the substance.
Specify if:
have been met at any time during a period of 12 months or longer (with the exception that Criterion A4, “Craving, or a strong desire or urge to use the substance,”may be met). Specify if:
|
” |
References
- ↑ 1.0 1.1 1.2 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
Risk Factors
- Antisocial personality disorder
- Behavioral disinhibition
- Conduct disorder
- Childhood maltreatment or trauma
- Early onset of substance problems
- Easy availability of the substance
- Limited early self-control[1]
Differential Diagnosis
- Other (or unknown) substance/medication-induced disorder
- Delirium
- Depressive disorder
- Major or mild neurocognitive disorder
- Psychotic disorder
- Other medical conditions
- Substance use disorders
- Use of Other or unknown substances without meeting criteria for other (or unknown) substance use disorder[1]
Other (or Unknown) Substance Withdrawal
Diagnostic Criteria
DSM-V Diagnostic Criteria for Other (or Unknown) Substance Withdrawal [1]
| “ |
AND
AND
AND
AND
|
” |
References
- ↑ 1.0 1.1 1.2 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
Epidemiology and Demographics
Prevalence
The prevalence of Other (or Unknown) Substance Withdrawal is unknown.[1]
Differential Diagnosis
- Dose reduction after extended dosing, but not meeting the criteria for other (or unknown)substance withdrawal
- Different types of other (or unknown) substance-related disorders
- Other toxic, metabolic, traumatic, neoplastic, vascular, or infectious disorders that impair brain function and cognition
- Substance withdrawal or other substance/medication-induced disorders[1]
Personality Change Due to Another Medical Condition
Diagnostic Criteria
DSM-V Diagnostic Criteria for Personality Change Due to Another Medical Condition[1]
| “ |
1 year.
AND
AND
AND E.The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning. Specify whether:
Unspecified type |
” |
References
- ↑ 1.0 1.1 1.2 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
Differential Diagnosis
- Another mental disorder due to another medical condition
- Depressive disorder due to brain tumor
- Chronic medical conditions associated with pain and disability
- Delirium or major neurocognitive disorder
- Other mental disorders
- Other personality disorders
- Substance use disorders[1]
- ↑ Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.